Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


3 AIDS Res Hum Retroviruses
2 Ann Intern Med
1 Antivir Ther
3 HIV Med
1 Int J Dermatol
2 J Infect Dis
1 J Virol
4 Lancet Infect Dis
1 Nature
1 Pediatrics
4 PLoS Med
6 PLoS One

    AIDS Res Hum Retroviruses

  1. TARAMASSO L, Riccardi N, Del Puente F, Bruzzone B, et al
    Tenofovir disoproxil fumarate/emtricitabine fits for all as appropriate HIV-1 preexposure prophylaxis?
    AIDS Res Hum Retroviruses. 2017 Nov 22. doi: 10.1089/AID.2017.0112.
    >> Share

  2. DINESHA TR, Boobalan J, Sivamalar S, Solomon SS, et al
    HIV, HBV and HCV prevalence among high risk populations in South India.
    AIDS Res Hum Retroviruses. 2017 Nov 22. doi: 10.1089/AID.2017.0253.
    >> Share

    Managing Expectations of an HIV Cure: What Should We Expect?
    AIDS Res Hum Retroviruses. 2017 Nov 22. doi: 10.1089/AID.2017.0247.
    >> Share

    Ann Intern Med

  4. ABARA WE, Qaseem A, Schillie S, McMahon BJ, et al
    Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-1106.
    >> Share

  5. KREBS E, Enns B, Evans E, Urada D, et al
    Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-0611.
    >> Share

    Antivir Ther

  6. PATEL RR, Presti R, Harrison LC, Powderly WG, et al
    Tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV prevention in women with osteoporosis: a case report and review of the literature.
    Antivir Ther. 2017 Nov 23. doi: 10.3851/IMP3208.
    >> Share


  7. ORIOLI IM, Dolk H, Lopez-Camelo JS, Mattos D, et al
    Prevalence and clinical profile of microcephaly in South America pre-Zika, 2005-14: prevalence and case-control study.
    BMJ. 2017;359:j5018.
    >> Share

    HIV Med

  8. ELGALIB A, Fidler S, Sabapathy K
    Hospital-based routine HIV testing in high-income countries: a systematic literature review.
    HIV Med. 2017 Nov 23. doi: 10.1111/hiv.12568.
    >> Share

  9. JAO J, Yu W, Patel K, Miller TL, et al
    Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12566.
    >> Share

  10. KOWALSKA JD, Aebi-Popp K, Loutfy M, Post FA, et al
    Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.
    HIV Med. 2017 Nov 21. doi: 10.1111/hiv.12565.
    >> Share

    Int J Dermatol

  11. BACIK LC, Chung C
    Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.
    Int J Dermatol. 2017 Nov 20. doi: 10.1111/ijd.13819.
    >> Share

    J Infect Dis

  12. JUSTICE AC, Erlandson KM, Miotti PG, Landay A, et al
    Can Biomarkers Advance HIV Research and Care in the ART Era?
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    >> Share

  13. CHAUDHURY CS, Sheehan J, Chairez C, Akoth E, et al
    No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
    J Infect Dis. 2017 Nov 17. doi: 10.1093.
    >> Share

    J Virol

  14. ADLAND E, Hill M, Lavandier N, Csala A, et al
    J Virol. 2017 Nov 22. pii: JVI.01685-17. doi: 10.1128/JVI.01685.
    >> Share

    Lancet Infect Dis

  15. LIN C, Franceschi S, Clifford GM
    Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30653.
    >> Share

  16. ZELENEV A, Li J, Mazhnaya A, Basu S, et al
    Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Lancet Infect Dis. 2017 Nov 15. pii: S1473-3099(17)30676.
    >> Share

  17. CASTAGNA A, Galli L
    Stepping up HIV-1 low-level viraemia surveillance in South Africa.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30680.
    >> Share

  18. HERMANS LE, Moorhouse M, Carmona S, Grobbee DE, et al
    Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Lancet Infect Dis. 2017 Nov 17. pii: S1473-3099(17)30681.
    >> Share


  19. ROSENBLOOM DIS, Hill AL, Laskey SB, Siliciano RF, et al
    Re-evaluating evolution in the HIV reservoir.
    Nature. 2017;551:E6-E9.
    >> Share


  20. CLAYTON HB, Lowry R, Basile KC, Demissie Z, et al
    Physical and Sexual Dating Violence and Nonmedical Use of Prescription Drugs.
    Pediatrics. 2017 Nov 20. pii: e20172289. doi: 10.1542/peds.2017-2289.
    >> Share

    PLoS Med

  21. EAKLE R, Gomez GB, Naicker N, Bothma R, et al
    HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    PLoS Med. 2017;14:e1002444.
    >> Share

  22. CHANDA MM, Ortblad KF, Mwale M, Chongo S, et al
    HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.
    PLoS Med. 2017;14:e1002442.
    >> Share

  23. DUNNING L, Francke JA, Mallampati D, MacLean RL, et al
    The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    PLoS Med. 2017;14:e1002446.
    >> Share

  24. BARNABAS RV, Celum C
    Closing the gaps in the HIV care continuum.
    PLoS Med. 2017;14:e1002443.
    >> Share

    PLoS One

  25. ROSSETTI B, Gagliardini R, Meini G, Sterrantino G, et al
    Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.
    PLoS One. 2017;12:e0187393.
    >> Share

  26. COURTNEY LP, Goco N, Woja J, Farris T, et al
    HIV prevalence and behavioral risk factors in the Sudan People's Liberation Army: Data from South Sudan.
    PLoS One. 2017;12:e0187689.
    >> Share

  27. SINGANO V, Amberbir A, Garone D, Kandionamaso C, et al
    The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi.
    PLoS One. 2017;12:e0188379.
    >> Share

  28. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    >> Share

  29. PLAZY M, Perriat D, Gumede D, Boyer S, et al
    Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers.
    PLoS One. 2017;12:e0186883.
    >> Share

  30. SOTGIU G, Falzon D, Hollo V, Kodmon C, et al
    Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.
    PLoS One. 2017;12:e0186499.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016